Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
| Autor: | Hutchings, Martin *, Mous, Rogier, Clausen, Michael Roost, Johnson, Peter, Linton, Kim M, Chamuleau, Martine E D, Lewis, David John, Sureda Balari, Anna, Cunningham, David, Oliveri, Roberto S, Elliott, Brian, DeMarco, Dena, Azaryan, Ada, Chiu, Christopher, Li, Tommy, Chen, Kuo-mei, Ahmadi, Tahamtan, Lugtenburg, Pieternella J |
|---|---|
| Zdroj: | In The Lancet 25 September-1 October 2021 398(10306):1157-1169 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|